GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report Farhat Nasim22 Nov 2024 5:40 PM ISTNew Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time...
Setback to Cipla: DoP rejects plea challenging NPPA order for Acivir Tablets pricing Farhat Nasim21 Nov 2024 6:16 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has rejected Cipla Ltd's review application challenging the ceiling price fixed for Acivir 800 mg...
Cipla Recalls Lanthanum Carbonate Tablets in US Farhat Nasim21 Nov 2024 1:38 PM ISTAs per the USFDA, New Jersey based Cipla USA, Inc is recalling the affected lot due to "complaints received of crushed and broken tablets".
NPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details Farhat Nasim20 Nov 2024 4:08 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for six drug formulations following review orders...
Cipla gets 8 USFDA observations for Virgonagar facility Ruchika Sharma14 Nov 2024 12:01 PM ISTMumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the Company's...
USFDA classifies Cipla Goa facility as VAI Ruchika Sharma4 Nov 2024 11:30 AM ISTMumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has classified the routine...
DoP orders NPPA to reassess price of Cipla's Advent, Synclar and Azee drugs Farhat Nasim30 Oct 2024 6:14 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals & Fertilizers, has issued orders to the National...
Cipla, Alkem vie for Rs 4,000 crore stake in India's largest stent manufacturer: Report Farhat Nasim18 Oct 2024 5:47 PM ISTMumbai: Pharmaceutical giants Cipla and Alkem Laboratories are in the final stages of a bidding war to acquire a controlling stake in Sahajanand...
Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP Farhat Nasim16 Oct 2024 4:59 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited (AHPL) challenging...
Indian Pharma Market Grows 5.3% in September, Sun Pharma, Cipla take the lead: Pharmarack report Farhat Nasim14 Oct 2024 5:45 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) witnessed a growth of 5.3% in September 2024, primarily driven by the robust performance of key...
Indian branded pharma Sector sees a decline in growth: Report Farhat Nasim9 Oct 2024 6:54 PM ISTCompanies such as Dr Reddys Laboratories (DRRD), Zydus Lifesciences (ZYDUSLIF), Lupin (LPC), and Mankind Pharma (MANKIND) expected to outperform on a...
Indian pharma sector set for mixed quarter: Report Ruchika Sharma9 Oct 2024 4:16 PM ISTNew Delhi: The Indian pharmaceutical industry is projected to experience a mixed quarter, with slower growth anticipated in the branded formulations,...
